Description

Introducing Gedorab-DSR: Comprehensive Relief for Acid Control and Digestive Comfort

Dual-Action Relief: Gedorab-DSR capsules combine Rabeprazole (20mg), a potent proton pump inhibitor (PPI), with Domperidone (30mg) in a sustained-release formulation. This combination effectively reduces gastric acid production and enhances gastric motility, providing comprehensive relief from acid reflux, GERD, and associated symptoms.
Extended Symptom Management: Rabeprazole in a sustained-release form ensures prolonged acid suppression, alleviating heartburn, acid regurgitation, and discomfort, while Domperidone enhances gastric emptying and reduces digestive discomfort throughout the day.
Convenient Once-Daily Dosing: Gedorab-DSR capsules simplify treatment adherence with their once-daily sustained-release formulation, improving patient compliance and treatment outcomes.
Proven Clinical Efficacy: Supported by clinical studies, Gedorab-DSR demonstrates robust efficacy in managing acid-related disorders and promoting digestive comfort, providing reassurance to healthcare providers and patients.
Pharmaceutical Excellence: Manufactured to stringent quality standards, Gedorab-DSR capsules uphold pharmaceutical integrity, ensuring safety, efficacy, and reliability in acid control and digestive health management.